BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20597059)

  • 1. [Approaches and problems in vaccine development against leishmaniasis].
    Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD
    Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
    Zahedifard F; Gholami E; Taheri T; Taslimi Y; Doustdari F; Seyed N; Torkashvand F; Meneses C; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2751. PubMed ID: 24675711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for leishmaniasis in the fore coming 25 years.
    Palatnik-de-Sousa CB
    Vaccine; 2008 Mar; 26(14):1709-24. PubMed ID: 18295939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in vaccines for leishmaniasis.
    Requena JM; Iborra S; Carrión J; Alonso C; Soto M
    Expert Opin Biol Ther; 2004 Sep; 4(9):1505-17. PubMed ID: 15335317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards a Leishmania vaccine.
    Tabbara KS
    Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against leishmaniasis.
    Modabber F
    Ann Trop Med Parasitol; 1995 Dec; 89 Suppl 1():83-8. PubMed ID: 8745930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress on vaccines against parasites.
    Engers HD; Bergquist R; Modabber F
    Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for visceral leishmaniasis: A review.
    Jain K; Jain NK
    J Immunol Methods; 2015 Jul; 422():1-12. PubMed ID: 25858230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
    Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
    Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania vaccines: progress and problems.
    Kedzierski L; Zhu Y; Handman E
    Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
    Dumonteil E
    Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibilities and challenges for developing a successful vaccine for leishmaniasis.
    Srivastava S; Shankar P; Mishra J; Singh S
    Parasit Vectors; 2016 May; 9(1):277. PubMed ID: 27175732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of Leishmania infection and the implications for vaccine development.
    Vanloubbeeck Y; Jones DE
    Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated Leishmania vaccines: a potential strategic alternative.
    Silvestre R; Cordeiro-da-Silva A; Ouaissi A
    Arch Immunol Ther Exp (Warsz); 2008; 56(2):123-6. PubMed ID: 18373245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis: prevention, parasite detection and treatment.
    Kobets T; Grekov I; Lipoldova M
    Curr Med Chem; 2012; 19(10):1443-74. PubMed ID: 22360481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.
    Mendonça SC
    Parasit Vectors; 2016 Sep; 9(1):492. PubMed ID: 27600664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation vaccines against leishmaniasis.
    Coler RN; Reed SG
    Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine candidates for leishmaniasis: a review.
    Nagill R; Kaur S
    Int Immunopharmacol; 2011 Oct; 11(10):1464-88. PubMed ID: 21616175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis: current status of vaccine development.
    Handman E
    Clin Microbiol Rev; 2001 Apr; 14(2):229-43. PubMed ID: 11292637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leishmaniasis: progress towards a vaccine.
    Launois P; Tacchini-Cottier F; Kieny MP
    Expert Rev Vaccines; 2008 Oct; 7(8):1277-87. PubMed ID: 18844599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.